Carl Zeiss Meditec AG Shareholders’ Equity Growth & History (AFX)
Carl Zeiss Meditec AG's shareholders’ equity was €2.13B for fiscal 2025.
View full Carl Zeiss Meditec AG company overviewCarl Zeiss Meditec AG annual shareholders’ equity history
| Fiscal year | Period ended | Shareholders’ equity | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-09-30 | €2.13B | €71.2M | +3.46% |
| 2024 | 2024-09-30 | €2.06B | −€116.4M | −5.36% |
| 2023 | 2023-09-30 | €2.17B | €142.8M | +7.03% |
| 2022 | 2022-09-30 | €2.03B | €370.8M | +22.34% |
| 2021 | 2021-09-30 | €1.66B | €227.6M | +15.90% |
| 2020 | 2020-09-30 | €1.43B | €33.3M | +2.38% |
| 2019 | 2019-09-30 | €1.40B | €105.0M | +8.12% |
| 2018 | 2018-09-30 | €1.29B | €78.1M | +6.42% |
| 2017 | 2017-09-30 | €1.22B | €417.5M | +52.33% |
| 2016 | 2016-09-30 | €797.8M | €44.0M | +5.83% |
| 2015 | 2015-09-30 | €753.9M | €38.6M | +5.40% |
| 2014 | 2014-09-30 | €715.3M | €16.9M | +2.41% |
| 2013 | 2013-09-30 | €698.4M | €43.4M | +6.63% |
| 2012 | 2012-09-30 | €655.0M | €56.0M | +9.34% |
| 2011 | 2011-09-30 | €599.0M | €26.8M | +4.68% |
| 2010 | 2010-09-30 | €572.3M | — | — |
Carl Zeiss Meditec AG quarterly shareholders’ equity
| Fiscal quarter | Period ended | Shareholders’ equity | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-09-30 | €2.12B | — | — |
| Q2 2025 | 2025-03-31 | €2.08B | — | — |
Carl Zeiss Meditec AG shareholders’ equity trends
Over the last five fiscal years, Carl Zeiss Meditec AG's shareholders’ equity increased from €1.43B to €2.13B, a change of €696.0M. The latest reported quarter, Q4 2025, shows €2.12B.
What shareholders’ equity means
Shareholders’ equity is the residual accounting value attributable to shareholders after liabilities are subtracted from assets. It can change through earnings, losses, dividends, share issuance, repurchases, and other comprehensive income.
reported shareholders’ equity
TickerStat standardizes stockholders’ or shareholders’ equity reported in company official filings at each balance-sheet date. Negative equity is retained because it can be economically meaningful. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Carl Zeiss Meditec AG source filings ↗